GMO Domestic Resilience ETF (DRES) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.72: the stock has moved about 28% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGMO Domestic Resilience ETF (DRES) trades at $28.46. The GMO Domestic Resilience ETF (DRES) is an actively managed fund targeting long-term capital appreciation by investing in U.S. companies deemed resilient to economic disruptions. Sector: Financials.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for DRES: DRES does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
GMO Domestic Resilience ETF (DRES) Financial Services Profile
The GMO Domestic Resilience ETF (DRES) is an actively managed fund from GMO, headquartered in Boston, US, focusing on U.S. companies with strong balance sheets and stable cash flows, aiming for long-term capital appreciation by identifying resilient businesses within the domestic market.
What Is the Investment Thesis for DRES?
The GMO Domestic Resilience ETF (DRES) presents an investment thesis centered on its actively managed strategy targeting U.S. companies with strong resilience to economic disruptions. With a Beta of 0.72, the fund exhibits lower volatility compared to the broader market, suggesting potential for downside protection during turbulent periods. The investment approach emphasizes companies possessing robust balance sheets and stable cash flows, which are critical attributes for sustained performance in various economic cycles. As an actively managed fund, DRES aims to generate alpha by leveraging GMO's expertise in security selection, potentially outperforming passive indices focused on broader market exposure. While its current market capitalization of $0.00 billion indicates a nascent or very small fund size, successful execution of its resilience-focused strategy could attract significant asset inflows, driving future growth. A potential risk lies in its concentrated investment strategy, which might underperform during periods of strong, broad-based economic expansion where more cyclical or growth-oriented sectors thrive. Investors should monitor the fund's sector allocations and its performance relative to comparable quality or resilience-focused strategies.
Based on FMP financials and quantitative analysis
DRES Key Highlights
The GMO Domestic Resilience ETF operates with a market capitalization of $0.00 billion, indicating a nascent stage or limited assets under management.
- A Beta of 0.72 suggests the fund exhibits lower volatility compared to the broader market, aligning with its resilience-focused investment objective.
- The fund does not currently distribute dividends to investors, prioritizing capital appreciation over income generation.
- DRES is an actively managed exchange-traded fund, allowing GMO's investment team discretion in selecting U.S. companies.
- The core investment strategy focuses on identifying U.S. companies with strong balance sheets and stable cash flows, aiming for economic resilience.
Who Are DRES's Competitors?
DRES is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
| BAM Brookfield Asset Management | $44.85 | +0.65% | $71.6B | 57 5-pillar |
| AMP Ameriprise Financial, Inc. | $490.91 | -0.79% | $44.1B | 77 5-pillar |
| ARES Ares Management Corporation | $117.55 | +0.84% | $38.6B | 57 5-pillar |
| TROW T. Rowe Price Group, Inc. | $104.62 | -1.14% | $22.4B | 80 5-pillar |
| ATHS Athene Holding Ltd. | $23.51 | -0.63% | $18.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DRES's Key Strengths?
Actively managed strategy allows for dynamic portfolio adjustments and potential outperformance.
- Focus on resilient U.S. companies with strong balance sheets and stable cash flows offers potential downside protection.
- Lower volatility (Beta of 0.72) compared to the broader market.
- Leverages the established investment expertise and brand reputation of GMO.
What Are DRES's Weaknesses?
Market capitalization of $0.00 billion indicates a very small fund, potentially limiting liquidity or institutional interest.
- Concentrated investment strategy could underperform during periods of strong, broad-based economic growth.
- Active management typically entails higher expense ratios compared to passive ETFs (though specific fees are not provided).
- Reliance on GMO's specific investment philosophy, which may not always align with market trends.
What Are the Key Risks for DRES?
Underperformance relative to broader market indices during periods of strong economic growth, due to its concentrated, defensive strategy.
- The fund's very low market capitalization ($0.00B) could lead to liquidity challenges or limit its appeal to larger institutional investors.
- Shifts in investor preferences away from resilience or quality-focused themes towards more growth-oriented or speculative investments.
- Reliance on the specific investment philosophy and security selection capabilities of GMO's management team, which may not always yield desired results.
- Increased competition within the thematic ETF space, potentially leading to fee compression or difficulty in attracting new assets.
What Threats Does DRES Face?
- Intense competition from numerous other thematic and actively managed ETFs.
- Underperformance relative to broader market indices during bull markets could deter investors.
- Changes in investor sentiment away from defensive or quality-focused strategies.
- Regulatory changes impacting the ETF industry or specific investment strategies.
What Are DRES's Competitive Advantages?
- Proprietary investment methodology developed by GMO for identifying resilient U.S. companies.
- Expertise and track record of GMO's investment management team in active security selection.
- Established brand reputation of GMO in the asset management industry.
- Active management approach, which can potentially generate alpha compared to passive index funds.
What Does DRES Do?
The GMO Domestic Resilience ETF (DRES) is an actively managed exchange-traded fund (ETF) offered by GMO, a Boston, US-based asset management firm. The fund's primary objective is to achieve long-term capital appreciation for its investors. DRES employs a thematic investment strategy, specifically targeting U.S. companies that GMO believes possess inherent resilience against economic disruptions and market volatility. This focus is centered on identifying businesses characterized by strong balance sheets, consistent cash flow generation, and robust operational stability, which are considered key attributes for navigating challenging economic landscapes. While the fund's name, 'Domestic Resilience ETF,' clearly indicates a focus on U.S. companies, its actively managed approach allows for a flexible investment mandate. GMO's investment team actively selects holdings, which may include a variety of financial instruments beyond just common stocks, all chosen for their perceived quality and potential for generating investor returns. The fund's market position is within the growing thematic ETF space, appealing to investors seeking exposure to quality-focused strategies that may offer a degree of downside protection. DRES aims to differentiate itself through its active management and specific criteria for identifying resilient U.S. enterprises, rather than tracking a passive index.
What Products and Services Does DRES Offer?
- Manages an actively traded exchange-traded fund (ETF) named GMO Domestic Resilience ETF (DRES).
- Aims to achieve long-term capital appreciation for investors.
- Invests primarily in U.S. companies believed to be resilient to economic disruptions.
- Focuses on identifying companies with strong balance sheets and stable cash flows.
- Utilizes active management to select a diverse range of financial instruments, not limited to just stocks.
- Seeks to provide downside protection during market downturns through its quality-focused strategy.
- Operates within the thematic ETF segment of the asset management industry.
How Does DRES Make Money?
- Generates revenue through management fees charged on the assets under management (AUM) of the DRES ETF.
- Aims to attract and retain investor capital by delivering competitive risk-adjusted returns through its active management strategy.
- Relies on the expertise of GMO's investment team for security selection and portfolio construction.
- Benefits from increased AUM, as management fees are typically a percentage of total assets.
What Industry Does DRES Operate In?
The GMO Domestic Resilience ETF (DRES) operates within the dynamic Financial Services sector, specifically the Asset Management industry. It occupies a niche in the rapidly expanding thematic ETF market, which has seen substantial growth as investors increasingly seek targeted exposure to specific investment themes rather than broad market indices. DRES's focus on 'resilience' aligns with a broader market trend towards quality and defensive strategies, particularly appealing during periods of economic uncertainty or heightened volatility. The competitive landscape for thematic ETFs is intense, with numerous providers offering specialized funds. DRES differentiates itself through its active management approach, leveraging GMO's established expertise in fundamental analysis and security selection, contrasting with the often passive nature of many thematic ETFs. Its emphasis on U.S. companies with strong balance sheets and stable cash flows positions it to potentially capture demand from investors seeking both capital appreciation and downside protection within the domestic equity market.
Who Are DRES's Key Customers?
- Institutional investors seeking exposure to resilience-focused U.S. equity strategies.
- Financial advisors and wealth managers allocating client portfolios to thematic ETFs.
- Individual investors looking for long-term capital appreciation with a focus on quality and downside protection.
- Investors seeking actively managed solutions within the U.S. equity market.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 47 |
| 2026-08-31 | 47 |
| 2026-09-08 | 47 |
| 2026-09-16 | 47 |
| 2026-09-24 | 47 |
| 2026-10-04 | 47 |
What changed?
The score has stayed at 47.
Over the same 30 days the stock moved -5.6%.
DRES Financials
Bull Case vs Bear Case
Bull Case
- Actively managed strategy allows for dynamic portfolio adjustments and potential outperformance.
- Focus on resilient U.S. companies with strong balance sheets and stable cash flows offers potential downside protection.
- Lower volatility (Beta of 0.72) compared to the broader market.
- Leverages the established investment expertise and brand reputation of GMO.
Bear Case
- Market capitalization of $0.00 billion indicates a very small fund, potentially limiting liquidity or institutional interest.
- Concentrated investment strategy could underperform during periods of strong, broad-based economic growth.
- Active management typically entails higher expense ratios compared to passive ETFs (though specific fees are not provided).
- Reliance on GMO's specific investment philosophy, which may not always align with market trends.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
DRES Latest News
-
Fluor Secures $7.5 Billion Share Of LNG Canada Phase 2 Expansion
benzinga · Sep 29, 2026
DRES Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DRES.
Price Targets
Wall Street price target analysis for DRES.
DRES MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for DRES; grades run from A+ (80-100) to F (below 30).
DRES Financials Stock FAQ
What does the GMO Domestic Resilience ETF (DRES) do?
The GMO Domestic Resilience ETF (DRES) is an actively managed exchange-traded fund from GMO that aims to achieve long-term capital appreciation. Its core strategy involves investing in U.S. companies that are identified as resilient to economic disruptions.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Resolved contradiction in source data regarding investment focus (U.S. vs. International) by prioritizing the fund's name 'Domestic Resilience ETF' and explicit 'AI Insight' linking DRES to U.S. companies, over the generic 'Business Description' which stated 'outside the United States' but did not explicitly name DRES.
- Market Cap of $0.00B is taken literally from source and interpreted as a very small/nascent fund.